Close

Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference Apr 1, 2024 07:00AM
Pre-Open Movers: West Fraser Timber Gains on Takeover Report, JNJ on Earnings Jul 19, 2022 09:13AM
Needham & Company Reiterates Buy Rating, $70 Price Target on Apellis Pharmaceuticals (APLS) May 5, 2022 06:49AM
Apellis Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference Apr 4, 2022 07:00AM
Apellis Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference Apr 4, 2022 07:00AM


Mar 16, 2022 01:27PM Needham & Company Reiterates Apellis Pharmaceuticals (APLS) at Buy, $70 PT, "Data Bode Well for Approval in GA"
Dec 31, 2021 09:26AM Apellis Pharmaceuticals (APLS) Stock Named Top Pick at Needham, Analyst Sees Over 45% Upside
Dec 31, 2021 05:59AM Needham & Company Adds Apellis Pharmaceuticals (APLS) to Conviction List, Calls Top Pick for 2022
Sep 10, 2021 06:54AM Apellis Pharmaceuticals (APLS) PT Lowered to $70 at Needham & Company
Jun 28, 2021 06:48AM Apellis Pharmaceuticals (APLS) PT Raised to $85 at Needham & Company After Previewing Phase 3 DERBY/OAKS Readout
May 17, 2021 02:04PM Apellis Pharmaceuticals (APLS) PT Raised to $65 at Needham & Company
Apr 17, 2018 09:22AM Pre-Open Movers 04/17: (RNDA) (ROKU) (NFLX) Higher; (BLCM) (LADR) (SEAC) Lower (more...)